4 | SEC Filings Hub

Filing metadata

Accession number: 0001104659-22-055332
Form type: Form 4
Filer: Nabriva Therapeutics plc
CIK: CIK 1641640
Filed: May 03, 2022
Reporting period: Apr 30, 2022
Description: Insider transaction

Documents

0001104659-22-055332-index.htm

Complete submission

0001104659-22-055332.txt

directory listing

Filed by

Nabriva Therapeutics plc